Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:04 AM
Ignite Modification Date:
2025-12-25 @ 1:04 AM
NCT ID:
NCT03969693
Eligibility Criteria:
Inclusion Criteria:
* Patients with an age of more than 15 years old when encountering local radiotherapy
* Histologically confirmed Hodgkin lymphoma or non-Hodgkin lymphoma
* A patient with resected thymoma referred for undergoing postoperative adjuvant radiotherapy is also acceptable and might be feasible
* The intended radiation field should involve the mediastinum region
* Malignant lymphoma patients who have undergone systemic chemotherapy with appropriate intensity and cycles tailored to the histologic subtype and oncological staging should start receiving RT within one month after restaging oncological surveys are performed before the course of mediastinal RT. Patient who must complete standard chemotherapy appropriate for the histologic subtype and staging of lymphoma and also be able to start radiation therapy within one month after restaging oncological surveys performed after completing chemotherapy
* Patients should have a fair to good performance status better than Eastern Cooperative Group (ECOG) of 2.
* Life expectancy of at least 12 months
Exclusion Criteria:
* Pregnant or breastfeeding
* Prior therapeutic radiation therapy delivered to breast, thoracic, or head \& neck
* Patients who have a serious medical illness
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
80 Years
Study:
NCT03969693
Study Brief:
Protocol Section:
NCT03969693